Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90

    August 2016 in “ American Journal Of Pathology ”
    Banafsheh Nazari, Lisa Rice, Giuseppina Stifano … Jeffrey L. Browning
    Studysummary This study reports that in systemic sclerosis, CD34+ dermal fibroblasts transition to CD34−, podoplanin+, and CD90+ fibroblasts across the dermis, suggesting a role in unchecked fibrosis.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ajp.amjpathol.org →
    Discuss this study in the Community →